Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi, shares how Chiesi is revolutionizing the lives of people living with rare diseases on a global scale. He also discusses key ways for life science companies to engage with patient communities, the importance of pharmaceutical companies maintaining high social and environmental standards, current market access barriers, and more!
To find out more about Impetus: https://www.meetwithimpetus.com
Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/
Impetus Digital Website: https://www.impetusdigital.com/
Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/
Impetus Digital Twitter: https://twitter.com/impetus_digital
Impetus YouTube: https://www.youtube.com/ImpetusDigital
Lawrence Bressler: https://www.linkedin.com/in/lawrencebressler/
Chiesi: https://www.chiesiusa.com/
Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.
Click the social media buttons to share this episode with your network!
To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com
Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/
Impetus Digital Website: Home Page
LinkedIn: https://www.linkedin.com/company/impetus-digital/
Twitter: impetus_digital
YouTube: Impetus Digital